Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | CTSD | P07339 | 1/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.39 |
| ▸ | LDHA | P00338 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | LDHB | P07195 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.33 |
| ▸ | KDM5C | P41229 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL31492006 | 0.90 | — | — | |
| Acetic Acid SCHEMBL7132795 | 0.87 | FFAR3 (0.47) | ALOX15CTSDFFAR3LDHAKDM4E | |
| Acetic Acid SCHEMBL4492710 | 0.87 | — | — | |
| Acetic Acid SCHEMBL6449854 | 0.87 | FFAR3 (0.47) | ALOX15CTSDFFAR3LDHAKDM4E | |
| Acetic Acid SCHEMBL3891856 | 0.84 | — | — | |
| Methacrylic Acid SCHEMBL17459015 | 0.83 | ALOX15 (0.44) | ALOX15CTSDFFAR3GAATDP1 | |
| Succinic Acid SCHEMBL2126097 | 0.81 | PHF8 (0.55) | ALOX15FFAR3KDM4EKMT2AHDAC3 | |
| Maleic Acid SCHEMBL28379898 | 0.79 | TSHR (0.50) | ALOX15KDM4EKMT2AMEN1GAA | |
| Oxalic Acid SCHEMBL283076 | 0.79 | ALOX15 (0.73) | ALOX15CTSDFFAR3KDM4EHDAC3 | |
| SCHEMBL55546 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 830 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371006-A | Long-acting slow-release sludge denitrification flora regulating agent, preparation method and application | 北京城市排水集团有限责任公司 | 2025-01-28 | — | — | CN | claimed |
| CN-108746656-B | Pre-alloyed powder for diamond products and preparation method thereof | 威海职业学院 | 2021-11-26 | — | — | CN | claimed |
| US-11174166-B2 | Methods for forming porous nanotube fabrics | ZEON CORPORATION (JP) | 2021-11-16 | — | — | US | claimed |
| US-20210188644-A1 | Methods for Forming Porous Nanotube Fabrics | NANTERO, INC. | 2021-06-24 | — | — | US | claimed |
| CN-108746656-A | Prealloy powder and preparation method thereof for diamond composition | 威海职业学院 | 2018-11-06 | — | — | CN | claimed |
| US-20260027113-A1 | PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE | SOLEY THERAPEUTICS INC (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4680608-A1 | 2,6-DIHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE DERIVATIVES AS ANTI-MALARIAL AGENTS | MMV Medicines for Malaria Venture (CH) | 2026-01-21 | — | — | EP | disclosed |
| EP-4653423-A1 | PYRAZOL-5-ETHER COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | CAC Nantong Chemical Co., Ltd. (CN) | 2025-11-26 | — | — | EP | disclosed |
| US-12465603-B2 | Phthalazinone based modulators for the treatment of disease | SOLEY THERAPEUTICS, INC. (US) | 2025-11-11 | — | — | US | disclosed |
| US-20250333424-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2025-10-30 | — | — | US | disclosed |
| US-20250320213-A1 | Nitrogen-Containing Heterocyclic Compounds | PFIZER INC. (US) | 2025-10-16 | — | — | US | disclosed |
| WO-2025215579-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS | PFIZER INC. (US) | 2025-10-16 | — | — | WO | disclosed |
| US-4632926-A | Quinazolinone derivatives which are active against coccidiosis | VETEM S.P.A. (IT) | 1986-12-30 | — | — | US | disclosed |
| EP-0098589-A1 | Quinazoline derivatives which are active against coccidiosis | VETEM S.p.A. (IT) | 1984-01-18 | — | — | EP | disclosed |
| US-4195087-A | BACTERICIDES, FEED ADDITIVES | ABIC, LTD. (IL) | 1980-03-25 | — | — | US | disclosed |
| US-4123437-A | REACTING A HYDRAZINE WITH AN ALKOXYCARBONYL ISOTHIOCYANATE, CYCLIZATION | CIBA-GEIGY CORPORATION (US) | 1978-10-31 | — | — | US | disclosed |
| US-4075222-A | VETERINARY MEDICINE, BACTERICIDES, FUNGICIDES, ANTIPROTOZOAN | ELI LILLY AND COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
| US-4001230-A | ANTIBACTERIAL, ANTIPROTAZOAL | ELI LILLY AND COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
| US-3980794-A | Method for promoting growth of poultry with 3-(5-nitro-2-imidazolyl)pyrazoles | ELI LILLY AND COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
| US-3947467-A | ANTIBACTERIAL, ANTIPROTOZOAL, ANTIFUNGAL | ELI LILLY AND COMPANY (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12465603-B2 | Phthalazinone based modulators for the treatment of disease | MKI67, BCL2, CCAR2 | ALOX15 1253/4885CTSD 2215/4885FFAR3 4618/4885 |
| US-20260027113-A1 | PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE | NCOR1, NOP56, NCOR2 | ALOX15 2235/4885CTSD 3264/4885FFAR3 1693/4885 |
| US-20250320213-A1 | Nitrogen-Containing Heterocyclic Compounds | HRH4, HNMT, NNT | ALOX15 155/4885CTSD 1072/4885FFAR3 450/4885 |
| US-20250333424-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, IRF3 | ALOX15 3037/4885CTSD 731/4885FFAR3 4383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.